Affected providers are recovering from a global IT outage that disrupted access to electronic health records (EHRs), cancelled surgeries and treatments, and posed potential risks to patient care. Technologies such as Microsoft and CrowdStrike were instrumental in resolving the issue. The outage raises questions about technology vulnerabilities and the need for effective contingency plans. No major lawsuits have yet been filed concerning the outage.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
